Peptide record

TPDB77555

Oncocin Blood-Brain Barrier modified_plain modified
23 amino acids
Basic Information
TPDB77555
Oncocin
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A 23-aa modified blood-brain barrier peptide sequence curated from Peptipedia, without an available 3D structural model.
C-terminal: Amidation
Sequence
VDKPPYLPRPRPPRRIYNR-NH2
Physicochemical Analysis
C119H189N41O28
ACEQGMFSTW
P
2642.07
11.84
7
1
5
+5
8.09
-1.730
46.52
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
2980
112.79
4
Residue Composition
number
0
A
5
R
2
N
1
D
0
C
0
E
0
Q
0
G
1
H
1
I
1
L
1
K
0
M
0
F
6
P
0
S
0
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 5 N: 2 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 1 I: 1 L: 1 K: 1 M: 0 F: 0 P: 6 S: 0 T: 0 W: 0 Y: 2 V: 1
Chemical Descriptors
23
C119H189N41O28
2642.07
11.84
+5
8.09
-1.730
Linear
Similarity
Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.002 min-1

Assay & Model

Efflux study ICU
Origin/Source
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
82%

Assay & Model

Capillary depletion
Origin/Source
% capillary

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
18%

Assay & Model

Capillary depletion
Origin/Source
% parenchyma

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.00044 mL/(g x min)

Assay & Model

Origin/Source
Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.02584 ml/g

Assay & Model

Origin/Source
Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
Permeability
Direct iodination
Additional Detail Fields 1 fields
Intravenous